nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—CYP1B1—ovarian cancer	0.167	0.51	CbGaD
Estradiol—ESR1—ovarian cancer	0.113	0.344	CbGaD
Estradiol—SLC22A3—Melphalan—ovarian cancer	0.058	0.133	CbGbCtD
Estradiol—ABCB1—ovarian cancer	0.048	0.146	CbGaD
Estradiol—NR1I2—Paclitaxel—ovarian cancer	0.0479	0.11	CbGbCtD
Estradiol—NR1I2—Docetaxel—ovarian cancer	0.0346	0.0794	CbGbCtD
Estradiol—SLCO1A2—Chlorambucil—ovarian cancer	0.0338	0.0775	CbGbCtD
Estradiol—ABCC10—Paclitaxel—ovarian cancer	0.0336	0.0771	CbGbCtD
Estradiol—ABCC10—Docetaxel—ovarian cancer	0.0243	0.0557	CbGbCtD
Estradiol—SLCO1B3—Paclitaxel—ovarian cancer	0.0188	0.0431	CbGbCtD
Estradiol—CYP1B1—Paclitaxel—ovarian cancer	0.0183	0.0419	CbGbCtD
Estradiol—ABCC10—Doxorubicin—ovarian cancer	0.0181	0.0416	CbGbCtD
Estradiol—ABCG2—Topotecan—ovarian cancer	0.0176	0.0402	CbGbCtD
Estradiol—SLCO1B3—Docetaxel—ovarian cancer	0.0136	0.0311	CbGbCtD
Estradiol—CYP1B1—Docetaxel—ovarian cancer	0.0132	0.0303	CbGbCtD
Estradiol—CYP1B1—Doxorubicin—ovarian cancer	0.00985	0.0226	CbGbCtD
Estradiol—ABCG2—Paclitaxel—ovarian cancer	0.00869	0.0199	CbGbCtD
Estradiol—ABCG2—Carboplatin—ovarian cancer	0.00818	0.0187	CbGbCtD
Estradiol—CYP3A7—Paclitaxel—ovarian cancer	0.00642	0.0147	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.00642	0.0147	CbGbCtD
Estradiol—ABCB1—Topotecan—ovarian cancer	0.00633	0.0145	CbGbCtD
Estradiol—ABCG2—Docetaxel—ovarian cancer	0.00628	0.0144	CbGbCtD
Estradiol—CYP3A5—Paclitaxel—ovarian cancer	0.00481	0.011	CbGbCtD
Estradiol—ABCG2—Doxorubicin—ovarian cancer	0.00468	0.0107	CbGbCtD
Estradiol—CYP3A7—Docetaxel—ovarian cancer	0.00464	0.0106	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.00464	0.0106	CbGbCtD
Estradiol—CYP2C8—Paclitaxel—ovarian cancer	0.00463	0.0106	CbGbCtD
Estradiol—ABCB1—Vinorelbine—ovarian cancer	0.00446	0.0102	CbGbCtD
Estradiol—CYP3A4—Topotecan—ovarian cancer	0.00379	0.00869	CbGbCtD
Estradiol—CYP3A5—Docetaxel—ovarian cancer	0.00348	0.00798	CbGbCtD
Estradiol—ESR2—ovarian follicle—ovarian cancer	0.00335	0.0544	CbGeAlD
Estradiol—CYP2C9—Paclitaxel—ovarian cancer	0.00323	0.0074	CbGbCtD
Estradiol—ABCB1—Paclitaxel—ovarian cancer	0.00313	0.00718	CbGbCtD
Estradiol—CYP3A4—Vinorelbine—ovarian cancer	0.00267	0.00613	CbGbCtD
Estradiol—ESR1—ovarian follicle—ovarian cancer	0.00229	0.0373	CbGeAlD
Estradiol—ABCB1—Docetaxel—ovarian cancer	0.00227	0.00519	CbGbCtD
Estradiol—CYP3A4—Paclitaxel—ovarian cancer	0.00188	0.0043	CbGbCtD
Estradiol—FABP2—embryo—ovarian cancer	0.00179	0.0291	CbGeAlD
Estradiol—ABCB1—Doxorubicin—ovarian cancer	0.00169	0.00387	CbGbCtD
Estradiol—ESRRB—gonad—ovarian cancer	0.0016	0.026	CbGeAlD
Estradiol—ESR2—oviduct—ovarian cancer	0.00147	0.0239	CbGeAlD
Estradiol—FABP2—epithelium—ovarian cancer	0.00146	0.0237	CbGeAlD
Estradiol—FABP2—uterine cervix—ovarian cancer	0.00145	0.0235	CbGeAlD
Estradiol—ESRRB—female reproductive system—ovarian cancer	0.00143	0.0233	CbGeAlD
Estradiol—CYP3A4—Docetaxel—ovarian cancer	0.00136	0.00311	CbGbCtD
Estradiol—GPER1—endometrium—ovarian cancer	0.00119	0.0193	CbGeAlD
Estradiol—ESRRB—testis—ovarian cancer	0.00115	0.0188	CbGeAlD
Estradiol—GPER1—uterus—ovarian cancer	0.00109	0.0178	CbGeAlD
Estradiol—AR—oviduct—ovarian cancer	0.00103	0.0167	CbGeAlD
Estradiol—CYP3A4—Doxorubicin—ovarian cancer	0.00101	0.00232	CbGbCtD
Estradiol—ESR1—oviduct—ovarian cancer	0.00101	0.0164	CbGeAlD
Estradiol—GPER1—female reproductive system—ovarian cancer	0.000983	0.016	CbGeAlD
Estradiol—GPER1—vagina—ovarian cancer	0.000889	0.0145	CbGeAlD
Estradiol—GPER1—testis—ovarian cancer	0.000794	0.0129	CbGeAlD
Estradiol—ESRRA—myometrium—ovarian cancer	0.000784	0.0127	CbGeAlD
Estradiol—FABP2—lymph node—ovarian cancer	0.000634	0.0103	CbGeAlD
Estradiol—ESRRA—uterine cervix—ovarian cancer	0.00061	0.00992	CbGeAlD
Estradiol—ESRRA—decidua—ovarian cancer	0.000581	0.00945	CbGeAlD
Estradiol—Fulvestrant—ESR1—ovarian cancer	0.00058	0.173	CrCbGaD
Estradiol—GPER1—lymph node—ovarian cancer	0.000575	0.00935	CbGeAlD
Estradiol—ESRRA—endometrium—ovarian cancer	0.000552	0.00897	CbGeAlD
Estradiol—SLCO4A1—myometrium—ovarian cancer	0.000531	0.00863	CbGeAlD
Estradiol—ESRRA—uterus—ovarian cancer	0.000509	0.00827	CbGeAlD
Estradiol—ESRRA—female reproductive system—ovarian cancer	0.000457	0.00743	CbGeAlD
Estradiol—AOX1—myometrium—ovarian cancer	0.000453	0.00736	CbGeAlD
Estradiol—ABCC10—myometrium—ovarian cancer	0.000441	0.00717	CbGeAlD
Estradiol—ESRRA—bone marrow—ovarian cancer	0.000432	0.00702	CbGeAlD
Estradiol—SLCO1B3—vagina—ovarian cancer	0.000426	0.00692	CbGeAlD
Estradiol—ESRRA—female gonad—ovarian cancer	0.000416	0.00676	CbGeAlD
Estradiol—ESRRA—vagina—ovarian cancer	0.000413	0.00672	CbGeAlD
Estradiol—SLCO4A1—decidua—ovarian cancer	0.000393	0.0064	CbGeAlD
Estradiol—Quinestrol—ESR1—ovarian cancer	0.000392	0.117	CrCbGaD
Estradiol—SLC22A3—myometrium—ovarian cancer	0.000377	0.00613	CbGeAlD
Estradiol—SLC22A11—female reproductive system—ovarian cancer	0.000375	0.0061	CbGeAlD
Estradiol—SLCO4A1—endometrium—ovarian cancer	0.000374	0.00607	CbGeAlD
Estradiol—ESR2—epithelium—ovarian cancer	0.000369	0.006	CbGeAlD
Estradiol—ESRRA—testis—ovarian cancer	0.000369	0.006	CbGeAlD
Estradiol—ESR2—uterine cervix—ovarian cancer	0.000366	0.00595	CbGeAlD
Estradiol—SLC22A3—embryo—ovarian cancer	0.000363	0.0059	CbGeAlD
Estradiol—AOX1—uterine cervix—ovarian cancer	0.000353	0.00573	CbGeAlD
Estradiol—ABCC10—uterine cervix—ovarian cancer	0.000343	0.00558	CbGeAlD
Estradiol—AOX1—decidua—ovarian cancer	0.000336	0.00546	CbGeAlD
Estradiol—ESR2—endometrium—ovarian cancer	0.000331	0.00538	CbGeAlD
Estradiol—AR—myometrium—ovarian cancer	0.000328	0.00534	CbGeAlD
Estradiol—ABCC10—decidua—ovarian cancer	0.000327	0.00531	CbGeAlD
Estradiol—ESR1—myometrium—ovarian cancer	0.000322	0.00524	CbGeAlD
Estradiol—SHBG—endometrium—ovarian cancer	0.000322	0.00523	CbGeAlD
Estradiol—AOX1—endometrium—ovarian cancer	0.000319	0.00518	CbGeAlD
Estradiol—SLCO1C1—testis—ovarian cancer	0.000312	0.00507	CbGeAlD
Estradiol—ABCC10—endometrium—ovarian cancer	0.00031	0.00504	CbGeAlD
Estradiol—ESR1—embryo—ovarian cancer	0.00031	0.00504	CbGeAlD
Estradiol—SLCO4A1—female reproductive system—ovarian cancer	0.000309	0.00503	CbGeAlD
Estradiol—ESR2—gonad—ovarian cancer	0.000307	0.00499	CbGeAlD
Estradiol—SLCO2B1—decidua—ovarian cancer	0.000306	0.00498	CbGeAlD
Estradiol—ESR2—uterus—ovarian cancer	0.000305	0.00496	CbGeAlD
Estradiol—SHBG—gonad—ovarian cancer	0.000299	0.00486	CbGeAlD
Estradiol—Mestranol—ESR1—ovarian cancer	0.000297	0.0885	CrCbGaD
Estradiol—Trilostane—ESR1—ovarian cancer	0.000297	0.0885	CrCbGaD
Estradiol—SHBG—uterus—ovarian cancer	0.000297	0.00482	CbGeAlD
Estradiol—AOX1—gonad—ovarian cancer	0.000296	0.00481	CbGeAlD
Estradiol—AOX1—uterus—ovarian cancer	0.000294	0.00478	CbGeAlD
Estradiol—SLC22A3—uterine cervix—ovarian cancer	0.000294	0.00477	CbGeAlD
Estradiol—ABCC10—gonad—ovarian cancer	0.000288	0.00468	CbGeAlD
Estradiol—ABCC10—uterus—ovarian cancer	0.000286	0.00465	CbGeAlD
Estradiol—SLCO4A1—vagina—ovarian cancer	0.00028	0.00455	CbGeAlD
Estradiol—ESR2—female reproductive system—ovarian cancer	0.000274	0.00446	CbGeAlD
Estradiol—SLCO1B1—female reproductive system—ovarian cancer	0.000272	0.00443	CbGeAlD
Estradiol—SLCO2B1—uterus—ovarian cancer	0.000268	0.00435	CbGeAlD
Estradiol—ESRRA—lymph node—ovarian cancer	0.000267	0.00435	CbGeAlD
Estradiol—SHBG—female reproductive system—ovarian cancer	0.000267	0.00434	CbGeAlD
Estradiol—SLC22A3—endometrium—ovarian cancer	0.000265	0.00432	CbGeAlD
Estradiol—AOX1—female reproductive system—ovarian cancer	0.000264	0.00429	CbGeAlD
Estradiol—Estriol—ESR1—ovarian cancer	0.000259	0.0772	CrCbGaD
Estradiol—ABCG2—myometrium—ovarian cancer	0.000258	0.0042	CbGeAlD
Estradiol—AR—epithelium—ovarian cancer	0.000258	0.00419	CbGeAlD
Estradiol—ABCC10—female reproductive system—ovarian cancer	0.000257	0.00418	CbGeAlD
Estradiol—CYP1B1—decidua—ovarian cancer	0.000257	0.00418	CbGeAlD
Estradiol—AR—uterine cervix—ovarian cancer	0.000256	0.00415	CbGeAlD
Estradiol—ESR1—epithelium—ovarian cancer	0.000253	0.00411	CbGeAlD
Estradiol—SHBG—bone marrow—ovarian cancer	0.000252	0.00409	CbGeAlD
Estradiol—ESR1—uterine cervix—ovarian cancer	0.000251	0.00408	CbGeAlD
Estradiol—SLCO4A1—testis—ovarian cancer	0.00025	0.00406	CbGeAlD
Estradiol—ESR2—female gonad—ovarian cancer	0.00025	0.00406	CbGeAlD
Estradiol—ESR2—vagina—ovarian cancer	0.000248	0.00403	CbGeAlD
Estradiol—SLC22A3—gonad—ovarian cancer	0.000246	0.004	CbGeAlD
Estradiol—AR—decidua—ovarian cancer	0.000243	0.00396	CbGeAlD
Estradiol—SHBG—female gonad—ovarian cancer	0.000243	0.00395	CbGeAlD
Estradiol—ABCC10—bone marrow—ovarian cancer	0.000243	0.00395	CbGeAlD
Estradiol—SHBG—vagina—ovarian cancer	0.000241	0.00392	CbGeAlD
Estradiol—SLCO2B1—female reproductive system—ovarian cancer	0.000241	0.00391	CbGeAlD
Estradiol—Estramustine—ESR1—ovarian cancer	0.000241	0.0718	CrCbGaD
Estradiol—AOX1—female gonad—ovarian cancer	0.00024	0.00391	CbGeAlD
Estradiol—ESR1—decidua—ovarian cancer	0.000239	0.00388	CbGeAlD
Estradiol—AOX1—vagina—ovarian cancer	0.000239	0.00388	CbGeAlD
Estradiol—ABCC10—female gonad—ovarian cancer	0.000234	0.0038	CbGeAlD
Estradiol—ABCC10—vagina—ovarian cancer	0.000232	0.00378	CbGeAlD
Estradiol—AR—endometrium—ovarian cancer	0.000231	0.00376	CbGeAlD
Estradiol—ESR1—endometrium—ovarian cancer	0.000227	0.00369	CbGeAlD
Estradiol—CYP1B1—gonad—ovarian cancer	0.000226	0.00368	CbGeAlD
Estradiol—SLCO1C1—lymph node—ovarian cancer	0.000226	0.00367	CbGeAlD
Estradiol—CYP1B1—uterus—ovarian cancer	0.000225	0.00366	CbGeAlD
Estradiol—ESR2—testis—ovarian cancer	0.000221	0.0036	CbGeAlD
Estradiol—SLC22A3—female reproductive system—ovarian cancer	0.00022	0.00358	CbGeAlD
Estradiol—SLCO2B1—female gonad—ovarian cancer	0.000219	0.00356	CbGeAlD
Estradiol—SHBG—testis—ovarian cancer	0.000215	0.0035	CbGeAlD
Estradiol—AR—gonad—ovarian cancer	0.000214	0.00348	CbGeAlD
Estradiol—AOX1—testis—ovarian cancer	0.000213	0.00346	CbGeAlD
Estradiol—AR—uterus—ovarian cancer	0.000213	0.00346	CbGeAlD
Estradiol—ESR1—gonad—ovarian cancer	0.00021	0.00342	CbGeAlD
Estradiol—ESR1—uterus—ovarian cancer	0.000209	0.0034	CbGeAlD
Estradiol—SLC22A1—vagina—ovarian cancer	0.000208	0.00338	CbGeAlD
Estradiol—ABCC10—testis—ovarian cancer	0.000207	0.00337	CbGeAlD
Estradiol—CYP1B1—female reproductive system—ovarian cancer	0.000202	0.00329	CbGeAlD
Estradiol—ABCG2—uterine cervix—ovarian cancer	0.000201	0.00327	CbGeAlD
Estradiol—SLC22A3—female gonad—ovarian cancer	0.0002	0.00325	CbGeAlD
Estradiol—SLC22A3—vagina—ovarian cancer	0.000199	0.00323	CbGeAlD
Estradiol—Estropipate—ESR1—ovarian cancer	0.000198	0.059	CrCbGaD
Estradiol—SLCO2B1—testis—ovarian cancer	0.000194	0.00316	CbGeAlD
Estradiol—CYP1A1—epithelium—ovarian cancer	0.000192	0.00313	CbGeAlD
Estradiol—AR—female reproductive system—ovarian cancer	0.000191	0.00311	CbGeAlD
Estradiol—ABCG2—decidua—ovarian cancer	0.000191	0.00311	CbGeAlD
Estradiol—CYP1A1—uterine cervix—ovarian cancer	0.000191	0.0031	CbGeAlD
Estradiol—ESR1—female reproductive system—ovarian cancer	0.000188	0.00305	CbGeAlD
Estradiol—CYP2C8—endometrium—ovarian cancer	0.000187	0.00304	CbGeAlD
Estradiol—CYP3A5—uterine cervix—ovarian cancer	0.000186	0.00303	CbGeAlD
Estradiol—CYP1B1—female gonad—ovarian cancer	0.000184	0.00299	CbGeAlD
Estradiol—Estrone—CYP1B1—ovarian cancer	0.000182	0.0544	CrCbGaD
Estradiol—ABCG2—endometrium—ovarian cancer	0.000182	0.00295	CbGeAlD
Estradiol—SLCO4A1—lymph node—ovarian cancer	0.000181	0.00294	CbGeAlD
Estradiol—SLCO1A2—testis—ovarian cancer	0.000179	0.00291	CbGeAlD
Estradiol—ALB—testis—ovarian cancer	0.000178	0.00289	CbGeAlD
Estradiol—SLC22A3—testis—ovarian cancer	0.000177	0.00289	CbGeAlD
Estradiol—AR—female gonad—ovarian cancer	0.000174	0.00283	CbGeAlD
Estradiol—AR—vagina—ovarian cancer	0.000173	0.00281	CbGeAlD
Estradiol—ESR1—female gonad—ovarian cancer	0.000171	0.00278	CbGeAlD
Estradiol—ESR1—vagina—ovarian cancer	0.00017	0.00276	CbGeAlD
Estradiol—ABCG2—uterus—ovarian cancer	0.000167	0.00272	CbGeAlD
Estradiol—CYP1B1—testis—ovarian cancer	0.000163	0.00265	CbGeAlD
Estradiol—ESR2—lymph node—ovarian cancer	0.000161	0.00261	CbGeAlD
Estradiol—CYP2C19—vagina—ovarian cancer	0.00016	0.00261	CbGeAlD
Estradiol—CYP1A1—uterus—ovarian cancer	0.000159	0.00258	CbGeAlD
Estradiol—CYP2C8—female reproductive system—ovarian cancer	0.000155	0.00252	CbGeAlD
Estradiol—AOX1—lymph node—ovarian cancer	0.000155	0.00251	CbGeAlD
Estradiol—AR—testis—ovarian cancer	0.000154	0.00251	CbGeAlD
Estradiol—ESR1—testis—ovarian cancer	0.000152	0.00247	CbGeAlD
Estradiol—ABCC10—lymph node—ovarian cancer	0.00015	0.00244	CbGeAlD
Estradiol—CYP1A1—female reproductive system—ovarian cancer	0.000143	0.00232	CbGeAlD
Estradiol—ABCG2—bone marrow—ovarian cancer	0.000142	0.00231	CbGeAlD
Estradiol—Ethinyl Estradiol—ESR1—ovarian cancer	0.000141	0.0422	CrCbGaD
Estradiol—SLCO2B1—lymph node—ovarian cancer	0.000141	0.00229	CbGeAlD
Estradiol—CYP2C8—vagina—ovarian cancer	0.00014	0.00228	CbGeAlD
Estradiol—CYP2C9—female reproductive system—ovarian cancer	0.000138	0.00224	CbGeAlD
Estradiol—ABCG2—female gonad—ovarian cancer	0.000137	0.00223	CbGeAlD
Estradiol—ABCG2—vagina—ovarian cancer	0.000136	0.00221	CbGeAlD
Estradiol—CYP1A1—female gonad—ovarian cancer	0.00013	0.00211	CbGeAlD
Estradiol—CYP1A1—vagina—ovarian cancer	0.000129	0.0021	CbGeAlD
Estradiol—ALB—lymph node—ovarian cancer	0.000129	0.00209	CbGeAlD
Estradiol—SLC22A3—lymph node—ovarian cancer	0.000129	0.00209	CbGeAlD
Estradiol—ABCB1—myometrium—ovarian cancer	0.000127	0.00207	CbGeAlD
Estradiol—CYP3A5—female gonad—ovarian cancer	0.000127	0.00207	CbGeAlD
Estradiol—CYP3A5—vagina—ovarian cancer	0.000126	0.00205	CbGeAlD
Estradiol—CYP2C8—testis—ovarian cancer	0.000125	0.00203	CbGeAlD
Estradiol—Conjugated Estrogens—ESR1—ovarian cancer	0.000124	0.0368	CrCbGaD
Estradiol—Estrone—ESR1—ovarian cancer	0.000123	0.0367	CrCbGaD
Estradiol—ABCB1—embryo—ovarian cancer	0.000122	0.00199	CbGeAlD
Estradiol—ABCG2—testis—ovarian cancer	0.000121	0.00197	CbGeAlD
Estradiol—CYP1B1—lymph node—ovarian cancer	0.000118	0.00192	CbGeAlD
Estradiol—AR—lymph node—ovarian cancer	0.000112	0.00182	CbGeAlD
Estradiol—Testosterone—CYP1B1—ovarian cancer	0.000111	0.0331	CrCbGaD
Estradiol—Estriol—ABCB1—ovarian cancer	0.00011	0.0328	CrCbGaD
Estradiol—ESR1—lymph node—ovarian cancer	0.00011	0.00179	CbGeAlD
Estradiol—CYP3A4—female reproductive system—ovarian cancer	0.000105	0.0017	CbGeAlD
Estradiol—Estramustine—ABCB1—ovarian cancer	0.000102	0.0305	CrCbGaD
Estradiol—ABCB1—epithelium—ovarian cancer	9.99e-05	0.00162	CbGeAlD
Estradiol—ABCB1—uterine cervix—ovarian cancer	9.91e-05	0.00161	CbGeAlD
Estradiol—ABCB1—decidua—ovarian cancer	9.44e-05	0.00153	CbGeAlD
Estradiol—ABCB1—endometrium—ovarian cancer	8.96e-05	0.00146	CbGeAlD
Estradiol—ABCG2—lymph node—ovarian cancer	8.81e-05	0.00143	CbGeAlD
Estradiol—CYP1A1—lymph node—ovarian cancer	8.36e-05	0.00136	CbGeAlD
Estradiol—ABCB1—gonad—ovarian cancer	8.31e-05	0.00135	CbGeAlD
Estradiol—ABCB1—uterus—ovarian cancer	8.26e-05	0.00134	CbGeAlD
Estradiol—ABCB1—female reproductive system—ovarian cancer	7.42e-05	0.00121	CbGeAlD
Estradiol—ABCB1—bone marrow—ovarian cancer	7.01e-05	0.00114	CbGeAlD
Estradiol—ABCB1—female gonad—ovarian cancer	6.75e-05	0.0011	CbGeAlD
Estradiol—ABCB1—vagina—ovarian cancer	6.71e-05	0.00109	CbGeAlD
Estradiol—Ethinyl Estradiol—ABCB1—ovarian cancer	6.01e-05	0.0179	CrCbGaD
Estradiol—ABCB1—testis—ovarian cancer	5.99e-05	0.000974	CbGeAlD
Estradiol—Conjugated Estrogens—ABCB1—ovarian cancer	5.25e-05	0.0156	CrCbGaD
Estradiol—Estrone—ABCB1—ovarian cancer	5.24e-05	0.0156	CrCbGaD
Estradiol—Bronchitis—Doxorubicin—ovarian cancer	4.57e-05	0.000434	CcSEcCtD
Estradiol—Dyspnoea—Paclitaxel—ovarian cancer	4.55e-05	0.000433	CcSEcCtD
Estradiol—Somnolence—Paclitaxel—ovarian cancer	4.54e-05	0.000432	CcSEcCtD
Estradiol—Arthralgia—Docetaxel—ovarian cancer	4.51e-05	0.000429	CcSEcCtD
Estradiol—Chest pain—Docetaxel—ovarian cancer	4.51e-05	0.000429	CcSEcCtD
Estradiol—Myalgia—Docetaxel—ovarian cancer	4.51e-05	0.000429	CcSEcCtD
Estradiol—Nausea—Vinorelbine—ovarian cancer	4.51e-05	0.000429	CcSEcCtD
Estradiol—Dyspepsia—Paclitaxel—ovarian cancer	4.49e-05	0.000427	CcSEcCtD
Estradiol—Neuropathy peripheral—Epirubicin—ovarian cancer	4.48e-05	0.000427	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	4.48e-05	0.000426	CcSEcCtD
Estradiol—Jaundice—Epirubicin—ovarian cancer	4.46e-05	0.000424	CcSEcCtD
Estradiol—Urinary tract infection—Epirubicin—ovarian cancer	4.45e-05	0.000423	CcSEcCtD
Estradiol—Conjunctivitis—Epirubicin—ovarian cancer	4.45e-05	0.000423	CcSEcCtD
Estradiol—Decreased appetite—Paclitaxel—ovarian cancer	4.44e-05	0.000422	CcSEcCtD
Estradiol—Dry mouth—Docetaxel—ovarian cancer	4.41e-05	0.00042	CcSEcCtD
Estradiol—Upper respiratory tract infection—Doxorubicin—ovarian cancer	4.41e-05	0.00042	CcSEcCtD
Estradiol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	4.41e-05	0.000419	CcSEcCtD
Estradiol—Fatigue—Paclitaxel—ovarian cancer	4.4e-05	0.000419	CcSEcCtD
Estradiol—Pollakiuria—Doxorubicin—ovarian cancer	4.39e-05	0.000417	CcSEcCtD
Estradiol—Pain—Paclitaxel—ovarian cancer	4.36e-05	0.000415	CcSEcCtD
Estradiol—Constipation—Paclitaxel—ovarian cancer	4.36e-05	0.000415	CcSEcCtD
Estradiol—Haematuria—Epirubicin—ovarian cancer	4.36e-05	0.000415	CcSEcCtD
Estradiol—Confusional state—Docetaxel—ovarian cancer	4.36e-05	0.000415	CcSEcCtD
Estradiol—ABCB1—lymph node—ovarian cancer	4.34e-05	0.000706	CbGeAlD
Estradiol—Photosensitivity reaction—Doxorubicin—ovarian cancer	4.33e-05	0.000412	CcSEcCtD
Estradiol—Hepatobiliary disease—Epirubicin—ovarian cancer	4.33e-05	0.000412	CcSEcCtD
Estradiol—Oedema—Docetaxel—ovarian cancer	4.33e-05	0.000412	CcSEcCtD
Estradiol—Anaphylactic shock—Docetaxel—ovarian cancer	4.33e-05	0.000412	CcSEcCtD
Estradiol—Weight increased—Doxorubicin—ovarian cancer	4.32e-05	0.000411	CcSEcCtD
Estradiol—Epistaxis—Epirubicin—ovarian cancer	4.31e-05	0.000411	CcSEcCtD
Estradiol—Infection—Docetaxel—ovarian cancer	4.3e-05	0.000409	CcSEcCtD
Estradiol—Weight decreased—Doxorubicin—ovarian cancer	4.29e-05	0.000409	CcSEcCtD
Estradiol—Sinusitis—Epirubicin—ovarian cancer	4.29e-05	0.000408	CcSEcCtD
Estradiol—Hyperglycaemia—Doxorubicin—ovarian cancer	4.28e-05	0.000408	CcSEcCtD
Estradiol—Pneumonia—Doxorubicin—ovarian cancer	4.26e-05	0.000405	CcSEcCtD
Estradiol—Shock—Docetaxel—ovarian cancer	4.26e-05	0.000405	CcSEcCtD
Estradiol—Nervous system disorder—Docetaxel—ovarian cancer	4.24e-05	0.000404	CcSEcCtD
Estradiol—Infestation NOS—Doxorubicin—ovarian cancer	4.23e-05	0.000403	CcSEcCtD
Estradiol—Infestation—Doxorubicin—ovarian cancer	4.23e-05	0.000403	CcSEcCtD
Estradiol—Tachycardia—Docetaxel—ovarian cancer	4.22e-05	0.000402	CcSEcCtD
Estradiol—Feeling abnormal—Paclitaxel—ovarian cancer	4.21e-05	0.0004	CcSEcCtD
Estradiol—Skin disorder—Docetaxel—ovarian cancer	4.2e-05	0.0004	CcSEcCtD
Estradiol—Gastrointestinal pain—Paclitaxel—ovarian cancer	4.17e-05	0.000397	CcSEcCtD
Estradiol—Neuropathy peripheral—Doxorubicin—ovarian cancer	4.15e-05	0.000395	CcSEcCtD
Estradiol—Haemoglobin—Epirubicin—ovarian cancer	4.13e-05	0.000393	CcSEcCtD
Estradiol—Jaundice—Doxorubicin—ovarian cancer	4.13e-05	0.000393	CcSEcCtD
Estradiol—Rhinitis—Epirubicin—ovarian cancer	4.12e-05	0.000392	CcSEcCtD
Estradiol—Conjunctivitis—Doxorubicin—ovarian cancer	4.11e-05	0.000392	CcSEcCtD
Estradiol—Urinary tract infection—Doxorubicin—ovarian cancer	4.11e-05	0.000392	CcSEcCtD
Estradiol—Hepatitis—Epirubicin—ovarian cancer	4.11e-05	0.000391	CcSEcCtD
Estradiol—Haemorrhage—Epirubicin—ovarian cancer	4.11e-05	0.000391	CcSEcCtD
Estradiol—Hypoaesthesia—Epirubicin—ovarian cancer	4.09e-05	0.000389	CcSEcCtD
Estradiol—Pharyngitis—Epirubicin—ovarian cancer	4.08e-05	0.000388	CcSEcCtD
Estradiol—Urinary tract disorder—Epirubicin—ovarian cancer	4.06e-05	0.000386	CcSEcCtD
Estradiol—Urticaria—Paclitaxel—ovarian cancer	4.05e-05	0.000386	CcSEcCtD
Estradiol—Oedema peripheral—Epirubicin—ovarian cancer	4.05e-05	0.000385	CcSEcCtD
Estradiol—Haematuria—Doxorubicin—ovarian cancer	4.04e-05	0.000384	CcSEcCtD
Estradiol—Connective tissue disorder—Epirubicin—ovarian cancer	4.04e-05	0.000384	CcSEcCtD
Estradiol—Abdominal pain—Paclitaxel—ovarian cancer	4.03e-05	0.000384	CcSEcCtD
Estradiol—Body temperature increased—Paclitaxel—ovarian cancer	4.03e-05	0.000384	CcSEcCtD
Estradiol—Urethral disorder—Epirubicin—ovarian cancer	4.03e-05	0.000383	CcSEcCtD
Estradiol—Hepatobiliary disease—Doxorubicin—ovarian cancer	4e-05	0.000381	CcSEcCtD
Estradiol—Epistaxis—Doxorubicin—ovarian cancer	3.99e-05	0.00038	CcSEcCtD
Estradiol—Sinusitis—Doxorubicin—ovarian cancer	3.97e-05	0.000378	CcSEcCtD
Estradiol—Visual impairment—Epirubicin—ovarian cancer	3.96e-05	0.000377	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	3.94e-05	0.000375	CcSEcCtD
Estradiol—Insomnia—Docetaxel—ovarian cancer	3.91e-05	0.000372	CcSEcCtD
Estradiol—Paraesthesia—Docetaxel—ovarian cancer	3.88e-05	0.00037	CcSEcCtD
Estradiol—Erythema multiforme—Epirubicin—ovarian cancer	3.88e-05	0.00037	CcSEcCtD
Estradiol—Dyspnoea—Docetaxel—ovarian cancer	3.86e-05	0.000367	CcSEcCtD
Estradiol—Somnolence—Docetaxel—ovarian cancer	3.85e-05	0.000366	CcSEcCtD
Estradiol—Eye disorder—Epirubicin—ovarian cancer	3.84e-05	0.000365	CcSEcCtD
Estradiol—Tinnitus—Epirubicin—ovarian cancer	3.83e-05	0.000364	CcSEcCtD
Estradiol—Haemoglobin—Doxorubicin—ovarian cancer	3.82e-05	0.000363	CcSEcCtD
Estradiol—Flushing—Epirubicin—ovarian cancer	3.81e-05	0.000363	CcSEcCtD
Estradiol—Cardiac disorder—Epirubicin—ovarian cancer	3.81e-05	0.000363	CcSEcCtD
Estradiol—Rhinitis—Doxorubicin—ovarian cancer	3.81e-05	0.000363	CcSEcCtD
Estradiol—Dyspepsia—Docetaxel—ovarian cancer	3.81e-05	0.000362	CcSEcCtD
Estradiol—Haemorrhage—Doxorubicin—ovarian cancer	3.8e-05	0.000362	CcSEcCtD
Estradiol—Hepatitis—Doxorubicin—ovarian cancer	3.8e-05	0.000362	CcSEcCtD
Estradiol—Hypoaesthesia—Doxorubicin—ovarian cancer	3.78e-05	0.00036	CcSEcCtD
Estradiol—Pharyngitis—Doxorubicin—ovarian cancer	3.77e-05	0.000359	CcSEcCtD
Estradiol—Decreased appetite—Docetaxel—ovarian cancer	3.76e-05	0.000358	CcSEcCtD
Estradiol—Hypersensitivity—Paclitaxel—ovarian cancer	3.76e-05	0.000358	CcSEcCtD
Estradiol—Urinary tract disorder—Doxorubicin—ovarian cancer	3.75e-05	0.000357	CcSEcCtD
Estradiol—Oedema peripheral—Doxorubicin—ovarian cancer	3.74e-05	0.000356	CcSEcCtD
Estradiol—Gastrointestinal disorder—Docetaxel—ovarian cancer	3.73e-05	0.000355	CcSEcCtD
Estradiol—Connective tissue disorder—Doxorubicin—ovarian cancer	3.73e-05	0.000355	CcSEcCtD
Estradiol—Fatigue—Docetaxel—ovarian cancer	3.73e-05	0.000355	CcSEcCtD
Estradiol—Angiopathy—Epirubicin—ovarian cancer	3.73e-05	0.000355	CcSEcCtD
Estradiol—Urethral disorder—Doxorubicin—ovarian cancer	3.72e-05	0.000354	CcSEcCtD
Estradiol—Immune system disorder—Epirubicin—ovarian cancer	3.71e-05	0.000353	CcSEcCtD
Estradiol—Mediastinal disorder—Epirubicin—ovarian cancer	3.7e-05	0.000352	CcSEcCtD
Estradiol—Constipation—Docetaxel—ovarian cancer	3.7e-05	0.000352	CcSEcCtD
Estradiol—Pain—Docetaxel—ovarian cancer	3.7e-05	0.000352	CcSEcCtD
Estradiol—Chills—Epirubicin—ovarian cancer	3.68e-05	0.000351	CcSEcCtD
Estradiol—Visual impairment—Doxorubicin—ovarian cancer	3.66e-05	0.000348	CcSEcCtD
Estradiol—Asthenia—Paclitaxel—ovarian cancer	3.66e-05	0.000348	CcSEcCtD
Estradiol—Alopecia—Epirubicin—ovarian cancer	3.63e-05	0.000345	CcSEcCtD
Estradiol—Pruritus—Paclitaxel—ovarian cancer	3.61e-05	0.000344	CcSEcCtD
Estradiol—Mental disorder—Epirubicin—ovarian cancer	3.6e-05	0.000342	CcSEcCtD
Estradiol—Erythema multiforme—Doxorubicin—ovarian cancer	3.59e-05	0.000342	CcSEcCtD
Estradiol—Erythema—Epirubicin—ovarian cancer	3.57e-05	0.00034	CcSEcCtD
Estradiol—Malnutrition—Epirubicin—ovarian cancer	3.57e-05	0.00034	CcSEcCtD
Estradiol—Feeling abnormal—Docetaxel—ovarian cancer	3.56e-05	0.000339	CcSEcCtD
Estradiol—Eye disorder—Doxorubicin—ovarian cancer	3.55e-05	0.000338	CcSEcCtD
Estradiol—Tinnitus—Doxorubicin—ovarian cancer	3.54e-05	0.000337	CcSEcCtD
Estradiol—Gastrointestinal pain—Docetaxel—ovarian cancer	3.54e-05	0.000337	CcSEcCtD
Estradiol—Flushing—Doxorubicin—ovarian cancer	3.53e-05	0.000336	CcSEcCtD
Estradiol—Cardiac disorder—Doxorubicin—ovarian cancer	3.53e-05	0.000336	CcSEcCtD
Estradiol—Flatulence—Epirubicin—ovarian cancer	3.52e-05	0.000335	CcSEcCtD
Estradiol—Tension—Epirubicin—ovarian cancer	3.51e-05	0.000334	CcSEcCtD
Estradiol—Dysgeusia—Epirubicin—ovarian cancer	3.5e-05	0.000333	CcSEcCtD
Estradiol—Diarrhoea—Paclitaxel—ovarian cancer	3.49e-05	0.000332	CcSEcCtD
Estradiol—Nervousness—Epirubicin—ovarian cancer	3.47e-05	0.00033	CcSEcCtD
Estradiol—Back pain—Epirubicin—ovarian cancer	3.46e-05	0.000329	CcSEcCtD
Estradiol—Angiopathy—Doxorubicin—ovarian cancer	3.45e-05	0.000328	CcSEcCtD
Estradiol—Muscle spasms—Epirubicin—ovarian cancer	3.44e-05	0.000327	CcSEcCtD
Estradiol—Immune system disorder—Doxorubicin—ovarian cancer	3.43e-05	0.000327	CcSEcCtD
Estradiol—Mediastinal disorder—Doxorubicin—ovarian cancer	3.42e-05	0.000326	CcSEcCtD
Estradiol—Abdominal pain—Docetaxel—ovarian cancer	3.42e-05	0.000325	CcSEcCtD
Estradiol—Body temperature increased—Docetaxel—ovarian cancer	3.42e-05	0.000325	CcSEcCtD
Estradiol—Chills—Doxorubicin—ovarian cancer	3.41e-05	0.000324	CcSEcCtD
Estradiol—Dizziness—Paclitaxel—ovarian cancer	3.37e-05	0.000321	CcSEcCtD
Estradiol—Alopecia—Doxorubicin—ovarian cancer	3.36e-05	0.00032	CcSEcCtD
Estradiol—Mental disorder—Doxorubicin—ovarian cancer	3.33e-05	0.000317	CcSEcCtD
Estradiol—Ill-defined disorder—Epirubicin—ovarian cancer	3.32e-05	0.000316	CcSEcCtD
Estradiol—Erythema—Doxorubicin—ovarian cancer	3.31e-05	0.000315	CcSEcCtD
Estradiol—Malnutrition—Doxorubicin—ovarian cancer	3.31e-05	0.000315	CcSEcCtD
Estradiol—Agitation—Epirubicin—ovarian cancer	3.29e-05	0.000313	CcSEcCtD
Estradiol—Flatulence—Doxorubicin—ovarian cancer	3.26e-05	0.00031	CcSEcCtD
Estradiol—Tension—Doxorubicin—ovarian cancer	3.25e-05	0.000309	CcSEcCtD
Estradiol—Vomiting—Paclitaxel—ovarian cancer	3.24e-05	0.000309	CcSEcCtD
Estradiol—Dysgeusia—Doxorubicin—ovarian cancer	3.24e-05	0.000308	CcSEcCtD
Estradiol—Malaise—Epirubicin—ovarian cancer	3.22e-05	0.000307	CcSEcCtD
Estradiol—Rash—Paclitaxel—ovarian cancer	3.22e-05	0.000306	CcSEcCtD
Estradiol—Dermatitis—Paclitaxel—ovarian cancer	3.21e-05	0.000306	CcSEcCtD
Estradiol—Nervousness—Doxorubicin—ovarian cancer	3.21e-05	0.000306	CcSEcCtD
Estradiol—Vertigo—Epirubicin—ovarian cancer	3.21e-05	0.000306	CcSEcCtD
Estradiol—Syncope—Epirubicin—ovarian cancer	3.21e-05	0.000305	CcSEcCtD
Estradiol—Back pain—Doxorubicin—ovarian cancer	3.2e-05	0.000304	CcSEcCtD
Estradiol—Headache—Paclitaxel—ovarian cancer	3.2e-05	0.000304	CcSEcCtD
Estradiol—Hypersensitivity—Docetaxel—ovarian cancer	3.19e-05	0.000303	CcSEcCtD
Estradiol—Testosterone—ABCB1—ovarian cancer	3.18e-05	0.00949	CrCbGaD
Estradiol—Muscle spasms—Doxorubicin—ovarian cancer	3.18e-05	0.000303	CcSEcCtD
Estradiol—Palpitations—Epirubicin—ovarian cancer	3.16e-05	0.000301	CcSEcCtD
Estradiol—Loss of consciousness—Epirubicin—ovarian cancer	3.14e-05	0.000299	CcSEcCtD
Estradiol—Cough—Epirubicin—ovarian cancer	3.12e-05	0.000297	CcSEcCtD
Estradiol—Asthenia—Docetaxel—ovarian cancer	3.1e-05	0.000295	CcSEcCtD
Estradiol—Hypertension—Epirubicin—ovarian cancer	3.09e-05	0.000294	CcSEcCtD
Estradiol—Ill-defined disorder—Doxorubicin—ovarian cancer	3.07e-05	0.000292	CcSEcCtD
Estradiol—Pruritus—Docetaxel—ovarian cancer	3.06e-05	0.000291	CcSEcCtD
Estradiol—Arthralgia—Epirubicin—ovarian cancer	3.04e-05	0.00029	CcSEcCtD
Estradiol—Chest pain—Epirubicin—ovarian cancer	3.04e-05	0.00029	CcSEcCtD
Estradiol—Myalgia—Epirubicin—ovarian cancer	3.04e-05	0.00029	CcSEcCtD
Estradiol—Agitation—Doxorubicin—ovarian cancer	3.04e-05	0.000289	CcSEcCtD
Estradiol—Anxiety—Epirubicin—ovarian cancer	3.03e-05	0.000289	CcSEcCtD
Estradiol—Nausea—Paclitaxel—ovarian cancer	3.03e-05	0.000288	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	3.02e-05	0.000288	CcSEcCtD
Estradiol—Discomfort—Epirubicin—ovarian cancer	3.01e-05	0.000286	CcSEcCtD
Estradiol—Malaise—Doxorubicin—ovarian cancer	2.98e-05	0.000284	CcSEcCtD
Estradiol—Dry mouth—Epirubicin—ovarian cancer	2.98e-05	0.000283	CcSEcCtD
Estradiol—Vertigo—Doxorubicin—ovarian cancer	2.97e-05	0.000283	CcSEcCtD
Estradiol—Syncope—Doxorubicin—ovarian cancer	2.97e-05	0.000282	CcSEcCtD
Estradiol—Diarrhoea—Docetaxel—ovarian cancer	2.96e-05	0.000282	CcSEcCtD
Estradiol—Confusional state—Epirubicin—ovarian cancer	2.94e-05	0.00028	CcSEcCtD
Estradiol—Palpitations—Doxorubicin—ovarian cancer	2.92e-05	0.000278	CcSEcCtD
Estradiol—Oedema—Epirubicin—ovarian cancer	2.92e-05	0.000278	CcSEcCtD
Estradiol—Anaphylactic shock—Epirubicin—ovarian cancer	2.92e-05	0.000278	CcSEcCtD
Estradiol—Loss of consciousness—Doxorubicin—ovarian cancer	2.91e-05	0.000277	CcSEcCtD
Estradiol—Infection—Epirubicin—ovarian cancer	2.9e-05	0.000276	CcSEcCtD
Estradiol—Cough—Doxorubicin—ovarian cancer	2.89e-05	0.000275	CcSEcCtD
Estradiol—Shock—Epirubicin—ovarian cancer	2.87e-05	0.000273	CcSEcCtD
Estradiol—Nervous system disorder—Epirubicin—ovarian cancer	2.86e-05	0.000272	CcSEcCtD
Estradiol—Dizziness—Docetaxel—ovarian cancer	2.86e-05	0.000272	CcSEcCtD
Estradiol—Hypertension—Doxorubicin—ovarian cancer	2.86e-05	0.000272	CcSEcCtD
Estradiol—Tachycardia—Epirubicin—ovarian cancer	2.85e-05	0.000271	CcSEcCtD
Estradiol—Skin disorder—Epirubicin—ovarian cancer	2.83e-05	0.00027	CcSEcCtD
Estradiol—Hyperhidrosis—Epirubicin—ovarian cancer	2.82e-05	0.000268	CcSEcCtD
Estradiol—Arthralgia—Doxorubicin—ovarian cancer	2.82e-05	0.000268	CcSEcCtD
Estradiol—Chest pain—Doxorubicin—ovarian cancer	2.82e-05	0.000268	CcSEcCtD
Estradiol—Myalgia—Doxorubicin—ovarian cancer	2.82e-05	0.000268	CcSEcCtD
Estradiol—Anxiety—Doxorubicin—ovarian cancer	2.81e-05	0.000267	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	2.8e-05	0.000266	CcSEcCtD
Estradiol—Discomfort—Doxorubicin—ovarian cancer	2.78e-05	0.000265	CcSEcCtD
Estradiol—Dry mouth—Doxorubicin—ovarian cancer	2.75e-05	0.000262	CcSEcCtD
Estradiol—Vomiting—Docetaxel—ovarian cancer	2.75e-05	0.000262	CcSEcCtD
Estradiol—Rash—Docetaxel—ovarian cancer	2.73e-05	0.00026	CcSEcCtD
Estradiol—Dermatitis—Docetaxel—ovarian cancer	2.72e-05	0.000259	CcSEcCtD
Estradiol—Confusional state—Doxorubicin—ovarian cancer	2.72e-05	0.000259	CcSEcCtD
Estradiol—Headache—Docetaxel—ovarian cancer	2.71e-05	0.000258	CcSEcCtD
Estradiol—Anaphylactic shock—Doxorubicin—ovarian cancer	2.7e-05	0.000257	CcSEcCtD
Estradiol—Oedema—Doxorubicin—ovarian cancer	2.7e-05	0.000257	CcSEcCtD
Estradiol—Infection—Doxorubicin—ovarian cancer	2.68e-05	0.000255	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	2.66e-05	0.000253	CcSEcCtD
Estradiol—Shock—Doxorubicin—ovarian cancer	2.66e-05	0.000253	CcSEcCtD
Estradiol—Nervous system disorder—Doxorubicin—ovarian cancer	2.65e-05	0.000252	CcSEcCtD
Estradiol—Insomnia—Epirubicin—ovarian cancer	2.64e-05	0.000251	CcSEcCtD
Estradiol—Tachycardia—Doxorubicin—ovarian cancer	2.63e-05	0.000251	CcSEcCtD
Estradiol—Skin disorder—Doxorubicin—ovarian cancer	2.62e-05	0.00025	CcSEcCtD
Estradiol—Paraesthesia—Epirubicin—ovarian cancer	2.62e-05	0.000249	CcSEcCtD
Estradiol—Hyperhidrosis—Doxorubicin—ovarian cancer	2.61e-05	0.000248	CcSEcCtD
Estradiol—Dyspnoea—Epirubicin—ovarian cancer	2.6e-05	0.000248	CcSEcCtD
Estradiol—Somnolence—Epirubicin—ovarian cancer	2.59e-05	0.000247	CcSEcCtD
Estradiol—Nausea—Docetaxel—ovarian cancer	2.57e-05	0.000245	CcSEcCtD
Estradiol—Dyspepsia—Epirubicin—ovarian cancer	2.57e-05	0.000244	CcSEcCtD
Estradiol—Decreased appetite—Epirubicin—ovarian cancer	2.54e-05	0.000241	CcSEcCtD
Estradiol—Gastrointestinal disorder—Epirubicin—ovarian cancer	2.52e-05	0.00024	CcSEcCtD
Estradiol—Fatigue—Epirubicin—ovarian cancer	2.52e-05	0.000239	CcSEcCtD
Estradiol—Pain—Epirubicin—ovarian cancer	2.5e-05	0.000237	CcSEcCtD
Estradiol—Constipation—Epirubicin—ovarian cancer	2.5e-05	0.000237	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	2.46e-05	0.000234	CcSEcCtD
Estradiol—Insomnia—Doxorubicin—ovarian cancer	2.44e-05	0.000232	CcSEcCtD
Estradiol—Paraesthesia—Doxorubicin—ovarian cancer	2.42e-05	0.000231	CcSEcCtD
Estradiol—Dyspnoea—Doxorubicin—ovarian cancer	2.41e-05	0.000229	CcSEcCtD
Estradiol—Feeling abnormal—Epirubicin—ovarian cancer	2.4e-05	0.000229	CcSEcCtD
Estradiol—Somnolence—Doxorubicin—ovarian cancer	2.4e-05	0.000228	CcSEcCtD
Estradiol—Gastrointestinal pain—Epirubicin—ovarian cancer	2.39e-05	0.000227	CcSEcCtD
Estradiol—Dyspepsia—Doxorubicin—ovarian cancer	2.38e-05	0.000226	CcSEcCtD
Estradiol—Decreased appetite—Doxorubicin—ovarian cancer	2.35e-05	0.000223	CcSEcCtD
Estradiol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	2.33e-05	0.000222	CcSEcCtD
Estradiol—Fatigue—Doxorubicin—ovarian cancer	2.33e-05	0.000221	CcSEcCtD
Estradiol—Urticaria—Epirubicin—ovarian cancer	2.32e-05	0.000221	CcSEcCtD
Estradiol—Pain—Doxorubicin—ovarian cancer	2.31e-05	0.00022	CcSEcCtD
Estradiol—Constipation—Doxorubicin—ovarian cancer	2.31e-05	0.00022	CcSEcCtD
Estradiol—Abdominal pain—Epirubicin—ovarian cancer	2.31e-05	0.000219	CcSEcCtD
Estradiol—Body temperature increased—Epirubicin—ovarian cancer	2.31e-05	0.000219	CcSEcCtD
Estradiol—Feeling abnormal—Doxorubicin—ovarian cancer	2.22e-05	0.000212	CcSEcCtD
Estradiol—Gastrointestinal pain—Doxorubicin—ovarian cancer	2.21e-05	0.00021	CcSEcCtD
Estradiol—Hypersensitivity—Epirubicin—ovarian cancer	2.15e-05	0.000205	CcSEcCtD
Estradiol—Urticaria—Doxorubicin—ovarian cancer	2.14e-05	0.000204	CcSEcCtD
Estradiol—Abdominal pain—Doxorubicin—ovarian cancer	2.13e-05	0.000203	CcSEcCtD
Estradiol—Body temperature increased—Doxorubicin—ovarian cancer	2.13e-05	0.000203	CcSEcCtD
Estradiol—Asthenia—Epirubicin—ovarian cancer	2.09e-05	0.000199	CcSEcCtD
Estradiol—Pruritus—Epirubicin—ovarian cancer	2.06e-05	0.000196	CcSEcCtD
Estradiol—Diarrhoea—Epirubicin—ovarian cancer	2e-05	0.00019	CcSEcCtD
Estradiol—Hypersensitivity—Doxorubicin—ovarian cancer	1.99e-05	0.000189	CcSEcCtD
Estradiol—Asthenia—Doxorubicin—ovarian cancer	1.94e-05	0.000184	CcSEcCtD
Estradiol—Dizziness—Epirubicin—ovarian cancer	1.93e-05	0.000184	CcSEcCtD
Estradiol—Pruritus—Doxorubicin—ovarian cancer	1.91e-05	0.000182	CcSEcCtD
Estradiol—Vomiting—Epirubicin—ovarian cancer	1.86e-05	0.000177	CcSEcCtD
Estradiol—Diarrhoea—Doxorubicin—ovarian cancer	1.85e-05	0.000176	CcSEcCtD
Estradiol—Rash—Epirubicin—ovarian cancer	1.84e-05	0.000175	CcSEcCtD
Estradiol—Dermatitis—Epirubicin—ovarian cancer	1.84e-05	0.000175	CcSEcCtD
Estradiol—Headache—Epirubicin—ovarian cancer	1.83e-05	0.000174	CcSEcCtD
Estradiol—Dizziness—Doxorubicin—ovarian cancer	1.79e-05	0.00017	CcSEcCtD
Estradiol—Nausea—Epirubicin—ovarian cancer	1.73e-05	0.000165	CcSEcCtD
Estradiol—Vomiting—Doxorubicin—ovarian cancer	1.72e-05	0.000163	CcSEcCtD
Estradiol—Rash—Doxorubicin—ovarian cancer	1.7e-05	0.000162	CcSEcCtD
Estradiol—Dermatitis—Doxorubicin—ovarian cancer	1.7e-05	0.000162	CcSEcCtD
Estradiol—Headache—Doxorubicin—ovarian cancer	1.69e-05	0.000161	CcSEcCtD
Estradiol—Nausea—Doxorubicin—ovarian cancer	1.6e-05	0.000153	CcSEcCtD
Estradiol—CYP2C8—Metabolism—SLC5A5—ovarian cancer	3.56e-06	5.42e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—BRIP1—ovarian cancer	3.56e-06	5.41e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PPP1CC—ovarian cancer	3.56e-06	5.41e-05	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	3.56e-06	5.41e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—SLC5A5—ovarian cancer	3.54e-06	5.39e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	3.5e-06	5.33e-05	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	3.5e-06	5.33e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PIK3CG—ovarian cancer	3.47e-06	5.28e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—CAV1—ovarian cancer	3.46e-06	5.27e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.45e-06	5.25e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—SLC2A1—ovarian cancer	3.44e-06	5.23e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—IL6—ovarian cancer	3.44e-06	5.23e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—CAV1—ovarian cancer	3.43e-06	5.22e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CAV1—ovarian cancer	3.43e-06	5.22e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—SLC2A1—ovarian cancer	3.42e-06	5.2e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	3.41e-06	5.18e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—IL2—ovarian cancer	3.38e-06	5.14e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	3.38e-06	5.14e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.37e-06	5.13e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PTEN—ovarian cancer	3.36e-06	5.11e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.36e-06	5.11e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.35e-06	5.1e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CYP1B1—ovarian cancer	3.3e-06	5.02e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PTEN—ovarian cancer	3.3e-06	5.01e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CYP1B1—ovarian cancer	3.28e-06	4.99e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PIK3CD—ovarian cancer	3.27e-06	4.97e-05	CbGpPWpGaD
Estradiol—AOX1—Metabolism—PIK3CA—ovarian cancer	3.25e-06	4.95e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—FASN—ovarian cancer	3.23e-06	4.92e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TERT—ovarian cancer	3.2e-06	4.87e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—CAV1—ovarian cancer	3.2e-06	4.86e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	3.19e-06	4.85e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—SLC5A5—ovarian cancer	3.18e-06	4.84e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.18e-06	4.83e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—AKT1—ovarian cancer	3.17e-06	4.83e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CG—ovarian cancer	3.16e-06	4.8e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—FASN—ovarian cancer	3.16e-06	4.8e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.15e-06	4.79e-05	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—AKT1—ovarian cancer	3.14e-06	4.77e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—ABCB1—ovarian cancer	3.14e-06	4.77e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CG—ovarian cancer	3.13e-06	4.76e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CG—ovarian cancer	3.12e-06	4.75e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—SLC5A5—ovarian cancer	3.1e-06	4.72e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—YAP1—ovarian cancer	3.09e-06	4.7e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—TYMS—ovarian cancer	3.08e-06	4.69e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—SLC2A1—ovarian cancer	3.07e-06	4.67e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.06e-06	4.65e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	3.05e-06	4.65e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PIK3CD—ovarian cancer	3.05e-06	4.64e-05	CbGpPWpGaD
Estradiol—AR—Gene Expression—MAPK3—ovarian cancer	3.05e-06	4.63e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.01e-06	4.57e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—SLC2A1—ovarian cancer	3e-06	4.56e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	3e-06	4.56e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—ABCB1—ovarian cancer	2.96e-06	4.51e-05	CbGpPWpGaD
Estradiol—AR—Gene Expression—MYC—ovarian cancer	2.96e-06	4.51e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CAV1—ovarian cancer	2.96e-06	4.5e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—FASN—ovarian cancer	2.95e-06	4.48e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CYP1B1—ovarian cancer	2.95e-06	4.48e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	2.93e-06	4.45e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.91e-06	4.43e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CG—ovarian cancer	2.91e-06	4.43e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—TYMS—ovarian cancer	2.91e-06	4.43e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PPP2R1A—ovarian cancer	2.91e-06	4.43e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—SLC5A5—ovarian cancer	2.9e-06	4.41e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.9e-06	4.4e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CYP1B1—ovarian cancer	2.87e-06	4.37e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—VEGFA—ovarian cancer	2.87e-06	4.37e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PIK3CB—ovarian cancer	2.85e-06	4.33e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—NRAS—ovarian cancer	2.84e-06	4.32e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL6ST—ovarian cancer	2.81e-06	4.27e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—SLC2A1—ovarian cancer	2.8e-06	4.26e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CD—ovarian cancer	2.77e-06	4.22e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CD—ovarian cancer	2.75e-06	4.18e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CD—ovarian cancer	2.75e-06	4.18e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.74e-06	4.17e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—MAPK3—ovarian cancer	2.72e-06	4.13e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ABCB1—ovarian cancer	2.72e-06	4.13e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—ABCB1—ovarian cancer	2.7e-06	4.11e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—APC—ovarian cancer	2.7e-06	4.1e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CG—ovarian cancer	2.7e-06	4.1e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.69e-06	4.09e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYP1B1—ovarian cancer	2.69e-06	4.08e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—TYMS—ovarian cancer	2.67e-06	4.06e-05	CbGpPWpGaD
Estradiol—AOX1—Metabolism—AKT1—ovarian cancer	2.66e-06	4.04e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PIK3CB—ovarian cancer	2.66e-06	4.04e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—TYMS—ovarian cancer	2.65e-06	4.04e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTEN—ovarian cancer	2.64e-06	4.01e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	2.61e-06	3.97e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	2.61e-06	3.97e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.6e-06	3.95e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—MAPK1—ovarian cancer	2.59e-06	3.93e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CD—ovarian cancer	2.56e-06	3.89e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PPP2R1A—ovarian cancer	2.55e-06	3.88e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—FASN—ovarian cancer	2.52e-06	3.83e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CAV1—ovarian cancer	2.48e-06	3.78e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—SLC5A5—ovarian cancer	2.48e-06	3.77e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTEN—ovarian cancer	2.46e-06	3.75e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—KRAS—ovarian cancer	2.44e-06	3.71e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ABCB1—ovarian cancer	2.43e-06	3.69e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CB—ovarian cancer	2.42e-06	3.68e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CB—ovarian cancer	2.4e-06	3.65e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—SLC2A1—ovarian cancer	2.39e-06	3.64e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CB—ovarian cancer	2.39e-06	3.64e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—YAP1—ovarian cancer	2.39e-06	3.63e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—TYMS—ovarian cancer	2.38e-06	3.62e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	2.38e-06	3.62e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CD—ovarian cancer	2.37e-06	3.61e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.37e-06	3.6e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	2.37e-06	3.6e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MAPK3—ovarian cancer	2.35e-06	3.57e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CAV1—ovarian cancer	2.35e-06	3.57e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.34e-06	3.56e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PIK3CA—ovarian cancer	2.33e-06	3.54e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—TYMS—ovarian cancer	2.32e-06	3.54e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTEN—ovarian cancer	2.3e-06	3.49e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP1B1—ovarian cancer	2.29e-06	3.49e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MYC—ovarian cancer	2.28e-06	3.47e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CG—ovarian cancer	2.26e-06	3.44e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTEN—ovarian cancer	2.26e-06	3.43e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—PIK3CA—ovarian cancer	2.24e-06	3.41e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.24e-06	3.41e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CB—ovarian cancer	2.23e-06	3.39e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ABCB1—ovarian cancer	2.21e-06	3.36e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—TYMS—ovarian cancer	2.17e-06	3.3e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TP53—ovarian cancer	2.17e-06	3.3e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CAV1—ovarian cancer	2.15e-06	3.27e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CAV1—ovarian cancer	2.14e-06	3.25e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CG—ovarian cancer	2.14e-06	3.25e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—ERBB2—ovarian cancer	2.09e-06	3.18e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTEN—ovarian cancer	2.09e-06	3.18e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—HRAS—ovarian cancer	2.08e-06	3.16e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTEN—ovarian cancer	2.07e-06	3.15e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTEN—ovarian cancer	2.07e-06	3.15e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CB—ovarian cancer	2.07e-06	3.14e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MTOR—ovarian cancer	2.07e-06	3.14e-05	CbGpPWpGaD
Estradiol—AR—Gene Expression—AKT1—ovarian cancer	2.05e-06	3.12e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.05e-06	3.12e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.04e-06	3.11e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	2.04e-06	3.1e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.03e-06	3.08e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CD—ovarian cancer	1.99e-06	3.02e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CXCL8—ovarian cancer	1.99e-06	3.02e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CG—ovarian cancer	1.96e-06	2.98e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CG—ovarian cancer	1.95e-06	2.96e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—FASN—ovarian cancer	1.94e-06	2.96e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CDKN1B—ovarian cancer	1.94e-06	2.95e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—AKT1—ovarian cancer	1.94e-06	2.94e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTEN—ovarian cancer	1.93e-06	2.93e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CAV1—ovarian cancer	1.92e-06	2.92e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.91e-06	2.91e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CASP3—ovarian cancer	1.9e-06	2.89e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—AKT1—ovarian cancer	1.9e-06	2.89e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL2—ovarian cancer	1.9e-06	2.89e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ABCB1—ovarian cancer	1.89e-06	2.87e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CD—ovarian cancer	1.88e-06	2.86e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CAV1—ovarian cancer	1.87e-06	2.85e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	1.86e-06	2.83e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—TYMS—ovarian cancer	1.86e-06	2.82e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCND1—ovarian cancer	1.85e-06	2.81e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.85e-06	2.81e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.83e-06	2.79e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—AKT1—ovarian cancer	1.83e-06	2.79e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CTNNB1—ovarian cancer	1.83e-06	2.79e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MMP9—ovarian cancer	1.8e-06	2.73e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTEN—ovarian cancer	1.79e-06	2.72e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.77e-06	2.69e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CAV1—ovarian cancer	1.75e-06	2.66e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.75e-06	2.66e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PIK3CA—ovarian cancer	1.74e-06	2.64e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CB—ovarian cancer	1.73e-06	2.64e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CD—ovarian cancer	1.72e-06	2.62e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CD—ovarian cancer	1.71e-06	2.6e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CG—ovarian cancer	1.71e-06	2.6e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.67e-06	2.54e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CB—ovarian cancer	1.64e-06	2.49e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PIK3CA—ovarian cancer	1.62e-06	2.46e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—VEGFA—ovarian cancer	1.61e-06	2.45e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—STAT3—ovarian cancer	1.6e-06	2.43e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.59e-06	2.42e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—NRAS—ovarian cancer	1.59e-06	2.42e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	1.59e-06	2.42e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—AKT1—ovarian cancer	1.58e-06	2.41e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.57e-06	2.39e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.54e-06	2.34e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MAPK3—ovarian cancer	1.53e-06	2.32e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—AKT1—ovarian cancer	1.52e-06	2.31e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CB—ovarian cancer	1.5e-06	2.28e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CD—ovarian cancer	1.5e-06	2.28e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTEN—ovarian cancer	1.5e-06	2.28e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CAV1—ovarian cancer	1.5e-06	2.27e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CB—ovarian cancer	1.49e-06	2.27e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MYC—ovarian cancer	1.48e-06	2.26e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CA—ovarian cancer	1.47e-06	2.24e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CA—ovarian cancer	1.46e-06	2.22e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CA—ovarian cancer	1.46e-06	2.22e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.46e-06	2.22e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MAPK1—ovarian cancer	1.45e-06	2.21e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EGFR—ovarian cancer	1.45e-06	2.21e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—TYMS—ovarian cancer	1.43e-06	2.18e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.43e-06	2.17e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—AKT1—ovarian cancer	1.42e-06	2.16e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTEN—ovarian cancer	1.41e-06	2.15e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.4e-06	2.13e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KRAS—ovarian cancer	1.37e-06	2.09e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.36e-06	2.07e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CA—ovarian cancer	1.36e-06	2.07e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.34e-06	2.04e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—AKT1—ovarian cancer	1.32e-06	2.01e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CB—ovarian cancer	1.31e-06	1.99e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—AKT1—ovarian cancer	1.3e-06	1.98e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTEN—ovarian cancer	1.3e-06	1.97e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTEN—ovarian cancer	1.29e-06	1.96e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CA—ovarian cancer	1.26e-06	1.92e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.22e-06	1.86e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TP53—ovarian cancer	1.22e-06	1.85e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—AKT1—ovarian cancer	1.2e-06	1.83e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.2e-06	1.82e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—AKT1—ovarian cancer	1.19e-06	1.82e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—AKT1—ovarian cancer	1.19e-06	1.81e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—HRAS—ovarian cancer	1.17e-06	1.77e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTEN—ovarian cancer	1.16e-06	1.76e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CAV1—ovarian cancer	1.15e-06	1.76e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTEN—ovarian cancer	1.13e-06	1.72e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL6—ovarian cancer	1.12e-06	1.7e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—AKT1—ovarian cancer	1.11e-06	1.69e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CA—ovarian cancer	1.06e-06	1.61e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTEN—ovarian cancer	1.06e-06	1.61e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.05e-06	1.6e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.04e-06	1.59e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—AKT1—ovarian cancer	1.03e-06	1.57e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CA—ovarian cancer	9.98e-07	1.52e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CD—ovarian cancer	9.24e-07	1.41e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CA—ovarian cancer	9.15e-07	1.39e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CA—ovarian cancer	9.1e-07	1.38e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTEN—ovarian cancer	9.02e-07	1.37e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—AKT1—ovarian cancer	8.63e-07	1.31e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CA—ovarian cancer	8.17e-07	1.24e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—AKT1—ovarian cancer	8.15e-07	1.24e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CB—ovarian cancer	8.06e-07	1.23e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CA—ovarian cancer	7.97e-07	1.21e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—AKT1—ovarian cancer	7.47e-07	1.14e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CA—ovarian cancer	7.45e-07	1.13e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—AKT1—ovarian cancer	7.43e-07	1.13e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTEN—ovarian cancer	6.96e-07	1.06e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—AKT1—ovarian cancer	6.67e-07	1.01e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—AKT1—ovarian cancer	6.51e-07	9.9e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CA—ovarian cancer	6.36e-07	9.68e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—AKT1—ovarian cancer	6.08e-07	9.25e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—AKT1—ovarian cancer	5.2e-07	7.91e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CA—ovarian cancer	4.91e-07	7.47e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—AKT1—ovarian cancer	4.01e-07	6.1e-06	CbGpPWpGaD
